Relationships Between Metabolic and Bariatric Surgery and Adverse Kidney Outcomes: An Analysis of a Retrospective

Kevin C Maki1,2, Stephanie L Dickinson3, Carol F Kirkpatrick1,4

  • 1Midwest Biomedical Research Addison Illinois USA.

Obesity Science & Practice
|December 30, 2025
PubMed
Abstract

Insights

Metabolic and bariatric surgery (MBS) significantly reduces the risk of adverse kidney outcomes in patients with obesity. This weight loss intervention helps preserve kidney function, even in those with type 2 diabetes.

Area of Science:

  • Nephrology
  • Metabolic Surgery
  • Obesity Medicine

Background:

  • Obesity is a major risk factor for chronic kidney disease (CKD).
  • Metabolic and bariatric surgery (MBS) is an effective intervention for sustained weight loss.
  • MBS may mitigate the risk of kidney disease associated with obesity.

Purpose of the Study:

  • To investigate the association between MBS and adverse kidney outcomes.
  • To compare kidney outcomes in obese patients who underwent MBS versus those who did not.

Main Methods:

  • Retrospective cohort analysis of 4322 patients undergoing MBS and 30,919 non-surgical controls.
  • Assessment of primary kidney composite outcomes, including low estimated glomerular filtration rate (eGFR), significant eGFR decline, or kidney failure-related death.
  • Multivariable Cox regression models, with and without inverse propensity of treatment weighting, were used to analyze data.

Main Results:

  • MBS was linked to a 53% lower incidence of the primary kidney composite outcome in patients with type 2 diabetes (T2D) and a 48% reduction in those without T2D.
  • Patients undergoing MBS experienced 48%-56% lower risks for secondary and tertiary kidney outcomes, irrespective of T2D status.
  • Follow-up averaged 6.1 years, demonstrating sustained benefits of MBS on kidney health.

Conclusions:

  • Metabolic and bariatric surgery is associated with substantially reduced risks of adverse kidney outcomes in individuals with obesity.
  • These findings support the use of MBS as a strategy to preserve kidney function in obese patients, including those with T2D.

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
270
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
211
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
149
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
297
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
286
External Anatomy of the Kidney01:21

External Anatomy of the Kidney

The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
3.2K